4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0000899243-16-016351
CEO & Chief Science Officer acquired 263,901 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Science Officer | 2016-03-17 | Grant or award | +184,466 | 1,129,902 | D | ||
| Zhang Jack Y. CEO & Chief Science Officer | 2016-03-17 | Grant or award | +79,435 | 767,666 | I | ||
| Derivatives | |||||||
| Zhang Jack Y. CEO & Chief Science Officer | 2016-03-17 | Grant or award · Employee Stock Option (right to buy) | +722,046 | 722,046 | D | ||
| Zhang Jack Y. CEO & Chief Science Officer | 2016-03-17 | Grant or award · Employee Stock Option (right to buy) | +310,930 | 310,930 | I | ||
Loading xslF345X03/doc4.xml…